Dunnwald LK[au] - Search Results

Year	Number of Results
1997	1
1999	3
2000	1
2001	1
2002	4
2003	3
2004	2
2005	1
2006	2
2007	4
2008	2
2009	1
2010	2
2011	2
2017	1
2018	1
2022	0

1

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Lindsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, Livingston RB. Eubank WB, et al. Among authors: dunnwald lk. Radiographics. 2002 Jan-Feb;22(1):5-17. doi: 10.1148/radiographics.22.1.g02ja055. Radiographics. 2002. PMID: 11796893 Review.

2

Blood flow-metabolism mismatch: good for the tumor, bad for the patient.

Mankoff DA, Dunnwald LK, Partridge SC, Specht JM. Mankoff DA, et al. Among authors: dunnwald lk. Clin Cancer Res. 2009 Sep 1;15(17):5294-6. doi: 10.1158/1078-0432.CCR-09-1448. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706819 Free PMC article.

3

Assessment of a statistical AIF extraction method for dynamic PET studies with ¹⁵O water and ¹⁸F fluorodeoxyglucose in locally advanced breast cancer patients.

O'Sullivan F, O'Sullivan JN, Huang J, Doot R, Muzi M, Schubert E, Peterson L, Dunnwald LK, Mankoff DM. O'Sullivan F, et al. Among authors: dunnwald lk. J Med Imaging (Bellingham). 2018 Jan;5(1):011010. doi: 10.1117/1.JMI.5.1.011010. Epub 2017 Nov 23. J Med Imaging (Bellingham). 2018. PMID: 29201941 Free PMC article.

4

Changes in Glucose Metabolism and Blood Flow Following Chemotherapy for Breast Cancer.

Mankoff DA, Dunnwald LK. Mankoff DA, et al. Among authors: dunnwald lk. PET Clin. 2006 Jan;1(1):71-81. doi: 10.1016/j.cpet.2005.09.001. PET Clin. 2006. PMID: 27156960

5

Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.

Kurland BF, Peterson LM, Lee JH, Linden HM, Schubert EK, Dunnwald LK, Link JM, Krohn KA, Mankoff DA. Kurland BF, et al. Among authors: dunnwald lk. J Nucl Med. 2011 Oct;52(10):1541-9. doi: 10.2967/jnumed.111.091439. Epub 2011 Sep 8. J Nucl Med. 2011. PMID: 21903739 Free PMC article.

6

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.

Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK, Petra PH, Peterson LM, Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA. Linden HM, et al. Among authors: dunnwald lk. J Clin Oncol. 2006 Jun 20;24(18):2793-9. doi: 10.1200/JCO.2005.04.3810. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682724

7

Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.

Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, Mankoff DA. Yao MS, et al. Among authors: dunnwald lk. Ann Surg Oncol. 2007 Oct;14(10):2985-93. doi: 10.1245/s10434-007-9473-x. Epub 2007 Jun 13. Ann Surg Oncol. 2007. PMID: 17564747

8

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA. Bellon JR, et al. Among authors: dunnwald lk. Am J Clin Oncol. 2004 Aug;27(4):407-10. doi: 10.1097/01.coc.0000128869.19357.9b. Am J Clin Oncol. 2004. PMID: 15289736

9

Technical aspects of sentinel node lymphoscintigraphy for breast cancer.

Dunnwald LK, Mankoff DA, Byrd DR, Anderson BO, Moe RE, Yeung RS, Eary JF. Dunnwald LK, et al. J Nucl Med Technol. 1999 Jun;27(2):106-11. J Nucl Med Technol. 1999. PMID: 10353106 Free article.

10

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Dunnwald LK, Rossing MA, Li CI. Dunnwald LK, et al. Breast Cancer Res. 2007;9(1):R6. doi: 10.1186/bcr1639. Breast Cancer Res. 2007. PMID: 17239243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results